id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-5570-0020,FDA,FDA-2017-D-5570,Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2020-02-26T05:00:00Z,2020,2,2020-02-26T05:00:00Z,,2024-11-06T23:33:16Z,,1,0,09000064843b60b4
FDA-2017-D-5570-0019,FDA,FDA-2017-D-5570,Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for Manufacturers of In Vitro Diagnostic Devices; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2020-02-26T05:00:00Z,2020,2,2020-02-26T05:00:00Z,,2020-02-26T14:53:23Z,2020-03860,0,0,09000064843b4ec1
FDA-2017-D-5570-0012,FDA,FDA-2017-D-5570,Select Updates for Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for Manufacturers of In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2018-11-29T05:00:00Z,2018,11,2018-11-29T05:00:00Z,2019-02-28T04:59:59Z,2024-11-12T22:50:46Z,2018-25959,1,0,090000648390c0fa
FDA-2017-D-5570-0013,FDA,FDA-2017-D-5570,Draft Guidance for Industry and FDA_Select Updates for CLIA of 1988 Waiver Applications for Manufacturers of IVD Devices_11-29-2018,Other,Guidance,2018-11-29T05:00:00Z,2018,11,2018-11-29T05:00:00Z,2019-02-28T04:59:59Z,2024-11-12T22:50:08Z,,1,0,090000648390cc70
FDA-2017-D-5570-0006,FDA,FDA-2017-D-5570,Select Updates for Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for  Manufacturers of In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period,Notice,Notice of Availability,2018-01-26T05:00:00Z,2018,1,2018-01-26T05:00:00Z,2018-03-31T03:59:59Z,2018-03-31T01:01:21Z,2018-01349,0,0,0900006482e6be59
FDA-2017-D-5570-0005,FDA,FDA-2017-D-5570,"Request for Extension from Coalition for CLIA Waiver Reform (Epstein Becker & Green, P.C.)",Other,Request for Extension,2018-01-08T05:00:00Z,2018,1,2018-01-08T05:00:00Z,,2018-01-08T16:20:10Z,,0,0,0900006482d9d48d
FDA-2017-D-5570-0001,FDA,FDA-2017-D-5570,Select Updates for Recommendations for Clinical Laboratory  Improvement Amendments of 1988 Waiver Applications for  Manufacturers of In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2017-11-29T05:00:00Z,2017,11,2017-11-29T05:00:00Z,2018-01-30T04:59:59Z,2018-01-14T03:27:08Z,2017-25775,0,0,0900006482cbbc77
FDA-2017-D-5570-0002,FDA,FDA-2017-D-5570,Select Updates for Recommendations for Clinical Laboratory  Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices Draft Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2017-11-29T05:00:00Z,2017,11,2017-11-29T05:00:00Z,2018-03-31T03:59:59Z,2024-11-07T01:12:28Z,,1,0,0900006482cbce4e